Tuula Ryde
16Patents
6h-index
13Co-inventors
63Inventor score
Filing activity: May 31, 2000 → Aug 25, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8512727B2 | Nanoparticulate meloxicam formulations | Emerging Cross-Sectional Technologies | 106 | Expired |
| US7101576B2 | Nanoparticulate megestrol formulations | Human Necessities | 56 | Expired |
| US6431478B1 | Small-scale mill and method thereof | Emerging Cross-Sectional Technologies | 44 | Expired |
| US7276249B2 | Nanoparticulate fibrate formulations | Emerging Cross-Sectional Technologies | 38 | Expired |
| US7320802B2 | Methods of treatment using nanoparticulate fenofibrate compositions | Emerging Cross-Sectional Technologies | 35 | Expired |
| US7390505B2 | Nanoparticulate topiramate formulations | Human Necessities | 10 | Expired |
| US10463673B2 | Nanoparticulate meloxicam formulations | Human Necessities | 3 | Active |
| US7927627B2 | Nanoparticulate fibrate formulations | Emerging Cross-Sectional Technologies | 2 | Active |
| US7931917B2 | Nanoparticulate fibrate formulations | Emerging Cross-Sectional Technologies | 2 | Active |
| US9107827B2 | Nanoparticulate megestrol formulations | Human Necessities | 2 | Active |
| US9101540B2 | Nanoparticulate megestrol formulations | Human Necessities | 1 | Active |
| US9044396B2 | Nanoparticulate megestrol formulations | General | 0 | Revoked |
| US10709713B2 | Nanoparticulate meloxicam formulations | Human Necessities | 0 | Active |
| US9101549B2 | Nanoparticulate megestrol formulations | Human Necessities | 0 | Active |
| US9040088B2 | Nanoparticulate megestrol formulations | Human Necessities | 0 | Active |
| US10471067B2 | Nanoparticulate meloxicam formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.